Inventor · disambiguated record
Melvin L. Rueppel
Also filed as: RUEPPEL MELVIN L
59 granted patents·15 pending applications·818 citations·filing 1975–2008
99Inventor score
Top patents by PatentIndex Score
74 records- 0198US6723752B2(R)-chiral halogenated substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP·Filed 2001·Granted Apr 20, 2004·53 cites·31 claims
- 0298US6458803B1Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activitySEARLE & CO·Filed 2001·Granted Oct 1, 2002·48 cites·13 claims
- 0397US6476075B1Use of substituted N, N-bis-benzyl aminoalcohol compounds inhibiting cholesteryl ester transfer protein activitySEARLE & CO·Filed 2001·Granted Nov 5, 2002·29 cites·13 claims
- 0496US6723753B2Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP·Filed 2002·Granted Apr 20, 2004·22 cites·34 claims
- 0596US6710089B2Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP·Filed 2002·Granted Mar 23, 2004·23 cites·16 claims
- 0695US6683099B2Substituted N,N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP·Filed 2002·Granted Jan 27, 2004·19 cites·16 claims
- 0795US6462092B1Use of substituted N, N-disubstituted reverse aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activitySEARLE & CO·Filed 2001·Granted Oct 8, 2002·23 cites·13 claims
- 0895US6451823B1Use of substituted N-phenoxy-N-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activitySEARLE & CO·Filed 2001·Granted Sep 17, 2002·18 cites·13 claims
- 0994US6677375B2Substituted N,N-bis-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP·Filed 2002·Granted Jan 13, 2004·19 cites·18 claims
- 1094US6455519B1Use of substituted N, N-disubstituted fused-heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activitySEARLE & CO·Filed 2001·Granted Sep 24, 2002·17 cites·14 claims
- 1194US6451830B1Use of substituted N,N-disubstituted non-fused heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activitySEARLE & CO·Filed 2001·Granted Sep 17, 2002·17 cites·13 claims
- 1294US6448295B1Use of substituted N-fused-phenyl-N-benzyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activitySEARLE & CO·Filed 2001·Granted Sep 10, 2002·17 cites·12 claims
- 1393US6765023B2Use of substituted N, N-disubstituted reverse aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activityPFIZER·Filed 2002·Granted Jul 20, 2004·14 cites·18 claims
- 1493US6521607B1(R)-chiral halogenated substituted N-phenoxy N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP·Filed 2001·Granted Feb 18, 2003·17 cites·31 claims
- 1593US6479552B2Use of substituted N, N-disubstituted diamino compounds for inhibiting cholesteryl ester transfer protein activitySEARLE & CO·Filed 2001·Granted Nov 12, 2002·15 cites·13 claims
- 1692US6803388B2(R)-Chiral halogenated substituted n,n-bis-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activityPFIZER·Filed 2001·Granted Oct 12, 2004·15 cites·29 claims
- 1792US6677379B2Substituted N,N-disubstituted diamino compounds useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP·Filed 2002·Granted Jan 13, 2004·12 cites·18 claims
- 1892US6677353B2Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP·Filed 2002·Granted Jan 13, 2004·12 cites·18 claims
- 1992US6624180B2Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascadePHARMACIA CORP·Filed 2001·Granted Sep 23, 2003·56 cites·41 claims
- 2092US6586433B2Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP·Filed 2001·Granted Jul 1, 2003·13 cites·31 claims
- 2192US6476057B1Use of substituted N, N-disubstituted cycloalkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activitySEARLE & CO·Filed 2001·Granted Nov 5, 2002·12 cites·12 claims
- 2292US6458849B1use of substituted N,N-disubstituted mercapto amino compounds for inhibiting cholesteryl ester transfer protein activitySEARLE & CO·Filed 2001·Granted Oct 1, 2002·12 cites·13 claims
- 2391US6696472B2Substituted N-phenoxy-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP·Filed 2002·Granted Feb 24, 2004·11 cites·18 claims
- 2491US6677341B2(R)-Chiral halogenated substituted heteroaryl benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP·Filed 2001·Granted Jan 13, 2004·13 cites·40 claims
- 2591US6544974B2(R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesteryl ester transfer protein activitySEARLE & CO·Filed 2001·Granted Apr 8, 2003·13 cites·14 claims
- 2691US6458852B1Use of substituted N, N-bis-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activitySEARLE & CO·Filed 2001·Granted Oct 1, 2002·10 cites·13 claims
- 2791US3970695AN-(perfluoroacyl)-N-phosphonomethyl glycine compounds, method of preparing sameMONSANTO CO·Filed 1975·Granted Jul 20, 1976·22 cites·4 claims
- 2890US6677380B2Substituted N, N-disubstituted mercapto amino compounds useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP·Filed 2002·Granted Jan 13, 2004·11 cites·18 claims
- 2990US6583183B2Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP·Filed 2001·Granted Jun 24, 2003·11 cites·25 claims
- 3089US6924313B1Substituted tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activityPFIZER·Filed 2002·Granted Aug 2, 2005·23 cites·8 claims
- 3189US6683113B2(R)-chiral halogenated substituted N,N-Bis-benzyl aminioalcohol compounds useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP·Filed 2001·Granted Jan 27, 2004·11 cites·31 claims
- 3288US6699898B2Substituted N,N-disubstituted non-fused heterocyclo amino compounds useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP GLOBAL PATENT D·Filed 2002·Granted Mar 2, 2004·11 cites·18 claims
- 3387US6696435B2Substituted N,N-disubstituted fused-heterocyclo amino compounds useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP·Filed 2002·Granted Feb 24, 2004·7 cites·20 claims
- 3487US6653316B1Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascadePHARMACIA CORP·Filed 2000·Granted Nov 25, 2003·17 cites·25 claims
- 3586US6867217B1Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascadePHARMACIA CORP·Filed 2000·Granted Mar 15, 2005·14 cites·20 claims
- 3686US6787570B2Substituted N-cycloalkyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activityPFIZER·Filed 2002·Granted Sep 7, 2004·13 cites·28 claims
- 3782US7015230B1Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascadePHARMACIA CORP·Filed 2000·Granted Mar 21, 2006·12 cites·10 claims
- 3882US6828338B2Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascadePHARMACIA CORP·Filed 2003·Granted Dec 7, 2004·13 cites·39 claims
- 3981US6458952B1Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascadePHARMACIA CORP·Filed 2000·Granted Oct 1, 2002·10 cites·2 claims
- 4080US6677382B1Substituted N,N-bis-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP·Filed 2002·Granted Jan 13, 2004·10 cites·18 claims
- 4179US6664255B1Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascadePHARMACIA CORP·Filed 2000·Granted Dec 16, 2003·7 cites·27 claims
- 4277US7015223B1Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascadePHARMACIA CORP·Filed 2000·Granted Mar 21, 2006·11 cites·41 claims
- 4377US6750342B1Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascadePHARMACIA CORP·Filed 2000·Granted Jun 15, 2004·7 cites·15 claims
- 4474US2007219274A1(R)-Chiral Halogenated Substituted Fused Heterocyclic Amino Compounds Useful for Inhibiting Cholesterol Ester Transfer Protein ActivityPFIZER·Filed 2007·Application pending·0 cites
- 4573US6861561B2Substituted aromatic policyclic tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activitySEARLE & CO·Filed 2002·Granted Mar 1, 2005·3 cites·5 claims
- 4673US4454043AColumn switching procedureMONSANTO CO·Filed 1980·Granted Jun 12, 1984·35 cites·17 claims
- 4771US7105559B2Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascadePHARMACIA CORP·Filed 2002·Granted Sep 12, 2006·5 cites·12 claims
- 4868US7700658B2(R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activityPFIZER·Filed 2008·Granted Apr 20, 2010·0 cites·4 claims
- 4966US4047926ATreatment of sugarcane with N-(perfluoroacyl)-N-phosphonomethyl glycineMONSANTO CO·Filed 1976·Granted Sep 13, 1977·5 cites·4 claims
- 5065US6908919B2Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascadePHARMACIA CORP·Filed 2002·Granted Jun 21, 2005·3 cites·27 claims
Showing the top 50 of 74 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →